Literature DB >> 25351711

Different scenarios for Candida parapsilosis fungaemia reveal high numbers of mixed C. parapsilosis and Candida orthopsilosis infections.

Leonardo Silva Barbedo1, Catarina Vaz2, Célia Pais2, Maria Helena Galdino Figueiredo-Carvalho1, Mauro de Medeiros Muniz1, Rosely Maria Zancope-Oliveira1, Paula Sampaio1.   

Abstract

Nosocomial fungal bloodstream infections (BSI) are increasing significantly in hospitalized patients and Candida parapsilosis has emerged as an important pathogen responsible for numerous outbreaks. The objective of this study was to evaluate C. parapsilosis sensu lato infection scenarios, regarding species distribution and strain relatedness. One hundred isolates of C. parapsilosis sensu lato derived from blood cultures and catheter tips were analysed by multiplex microsatellite typing and by sequencing D1/D2 regions of the ribosomal DNA. Our results indicate that 9.5 % of patients presented infections due to C. parapsilosis and Candida orthopsilosis, 57.1 % due to C. parapsilosis, 28.3 % due to C. orthopsilosis and 4.8 % due to Candida metapsilosis. Eighty per cent of the C. parapsilosis BSIs were due to a single strain that was also identified in the catheter, but in 10 % of the cases C. parasilosis was identified in the catheter but the BSI was due to C. orthopsilosis. There is a significant probability that C. parapsilosis isolates collected from the same patient at more than 3 months interval are of different strains (P = 0.0179). Moreover, several isolates were identified persistently in the same hospital, infecting six different patients. The incidence of polyfungal BSI infections with C. parapsilosis and C. orthopsilosis is reported herein for the first time, emphasizing the fact that the species identified in the catheter is not always responsible for the BSI, thus impacting the treatment strategy. The observation that strains can remain in the hospital environment for years highlights the possible existence of reservoirs and reinforces the need for accurate genotyping tools, such as the markers used for elucidating epidemiological associations and detecting outbreaks.
© 2015 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25351711     DOI: 10.1099/jmm.0.080655-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

1.  Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China.

Authors:  Xiaobo Feng; Bo Ling; Xianwei Yang; Wanqing Liao; Weihua Pan; Zhirong Yao
Journal:  Mycopathologia       Date:  2015-07-31       Impact factor: 2.574

2.  The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters.

Authors:  Roberta Fais; Mariagrazia Di Luca; Cosmeri Rizzato; Paola Morici; Daria Bottai; Arianna Tavanti; Antonella Lupetti
Journal:  Front Microbiol       Date:  2017-11-13       Impact factor: 5.640

3.  Comparison of four molecular approaches to identify Candida parapsilosis complex species.

Authors:  Leonardo Silva Barbedo; Maria Helena Galdino Figueiredo-Carvalho; Mauro de Medeiros Muniz; Rosely Maria Zancopé-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-02-16       Impact factor: 2.743

4.  Design and validation of a multiplex PCR protocol for microsatellite typing of Candida parapsilosis sensu stricto isolates.

Authors:  Camino Trobajo-Sanmartín; Guillermo Ezpeleta; Célia Pais; Elena Eraso; Guillermo Quindós
Journal:  BMC Genomics       Date:  2018-09-29       Impact factor: 3.969

5.  High-resolution fingerprinting of Candida parapsilosis isolates suggests persistence and transmission of infections among neonatal intensive care unit patients in Kuwait.

Authors:  Mohammad Asadzadeh; Suhail Ahmad; Noura Al-Sweih; Ferry Hagen; Jacques F Meis; Ziauddin Khan
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

6.  Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts, Candida orthopsilosis, and Candida metapsilosis: An Iranian Multicenter Study (2014-2019).

Authors:  Amir Arastehfar; Sadegh Khodavaisy; Farnaz Daneshnia; Mohammad-Javad Najafzadeh; Shahram Mahmoudi; Arezoo Charsizadeh; Mohammad-Reza Salehi; Hossein Zarrinfar; Abbas Raeisabadi; Somayeh Dolatabadi; Zahra Zare Shahrabadi; Kamiar Zomorodian; Weihua Pan; Ferry Hagen; Teun Boekhout
Journal:  Front Cell Infect Microbiol       Date:  2019-07-30       Impact factor: 5.293

7.  Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.

Authors:  Fulgence Kondo Kassi; Pascal Drakulovski; Virginie Bellet; Frédéric Roger; Amélie Chabrol; Donika Krasteva; Adama Doumbia; Roland Landman; Aka Kakou; Jacques Reynes; Eric Delaporte; Hervé Eby Ignace Menan; Sébastien Bertout
Journal:  PLoS Negl Trop Dis       Date:  2019-11-18

8.  Genetic diversity assessed using PFGE, MLP and MLST in Candida spp. candidemia isolates obtained from a Brazilian hospital.

Authors:  Heliara Maria Spina Canela; Bárbara Cardoso; Miliane Rodrigues Frazão; Juliana Pfrimer Falcão; Lucia Helena Vitali; Roberto Martinez; Márcia Eliana da Silva Ferreira
Journal:  Braz J Microbiol       Date:  2021-02-20       Impact factor: 2.476

9.  The identification and differentiation of the Candida parapsilosis complex species by polymerase chain reaction-restriction fragment length polymorphism of the internal transcribed spacer region of the rDNA.

Authors:  Leonardo Silva Barbedo; Maria Helena Galdino Figueiredo-Carvalho; Mauro de Medeiros Muniz; Rosely Maria Zancopé-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04       Impact factor: 2.743

10.  Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis.

Authors:  Mohammad Asadzadeh; Suhail Ahmad; Ferry Hagen; Jacques F Meis; Noura Al-Sweih; Ziauddin Khan
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.